Literature DB >> 17873830

Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate.

Lei Chen1, Hong-Yu Zhang.   

Abstract

Accumulating evidence indicates that consumption of tea, especially green tea, is good for preventing cancer. To elucidate the cancer preventive mechanisms of green tea, much effort has been devoted to investigating the anticancer effects of (-)-epigallocatechin-3-gallate (EGCG), the major component of green tea. It has been revealed that EGCG restrained carcinogenesis in a variety of tissues through inhibition of mitogen-activated protein kinases (MAPK), growth factor-related cell signaling, activation of activator protein 1 (AP-1) and nuclear factor-B (NF-kappaB), topoisomerase I, matrix metalloproteinases and other potential targets. Therefore, EGCG is a multipotent anticancer agent, which not only provides solid evidence to support the anticancer potential of green tea, but also offers new clues for discovering multiple-targeted anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873830      PMCID: PMC6149506          DOI: 10.3390/12050946

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  61 in total

1.  Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity.

Authors:  G Zhang; Y Miura; K Yagasaki
Journal:  Cancer Lett       Date:  2000-10-31       Impact factor: 8.679

2.  Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells.

Authors:  S Islam; N Islam; T Kermode; B Johnstone; H Mukhtar; R W Moskowitz; V M Goldberg; C J Malemud; T M Haqqi
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

3.  Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan.

Authors:  M Inoue; K Tajima; K Hirose; N Hamajima; T Takezaki; T Kuroishi; S Tominaga
Journal:  Cancer Causes Control       Date:  1998-03       Impact factor: 2.506

4.  Green tea constituent (--)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells.

Authors:  S J Berger; S Gupta; C A Belfi; D M Gosky; H Mukhtar
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

Review 5.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

6.  Cancer-preventive effects of drinking green tea among a Japanese population.

Authors:  K Imai; K Suga; K Nakachi
Journal:  Prev Med       Date:  1997 Nov-Dec       Impact factor: 4.018

Review 7.  Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.

Authors:  Y J Surh; K S Chun; H H Cha; S S Han; Y S Keum; K K Park; S S Lee
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

8.  Human endothelial cell life extension by telomerase expression.

Authors:  J Yang; E Chang; A M Cherry; C D Bangs; Y Oei; A Bodnar; A Bronstein; C P Chiu; G S Herron
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

9.  Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate.

Authors:  S K Katiyar; F Afaq; K Azizuddin; H Mukhtar
Journal:  Toxicol Appl Pharmacol       Date:  2001-10-15       Impact factor: 4.219

Review 10.  NF-kappaB in cancer: a marked target.

Authors:  Anning Lin; Michael Karin
Journal:  Semin Cancer Biol       Date:  2003-04       Impact factor: 15.707

View more
  30 in total

1.  Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway.

Authors:  Dan Yang; Jing Liu; Cui Tian; Yong Zeng; Yue-hong Zheng; Quan Fang; Hui-hua Li
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

2.  Effects of tea polyphenols on proliferation and apoptosis of cadmium-transformed cells.

Authors:  Min Wang; Yi-Xiong Lei
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 3.  Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.

Authors:  Alexandra M Fajardo; Gary A Piazza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-05-28       Impact factor: 4.052

4.  Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.

Authors:  Wei He; Li-Xia Li; Qing-Jiao Liao; Chun-Lan Liu; Xu-Lin Chen
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

Review 5.  New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.

Authors:  Shahnjayla K Connors; Ganna Chornokur; Nagi B Kumar
Journal:  Nutr Cancer       Date:  2011-11-18       Impact factor: 2.900

6.  Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides.

Authors:  Haiyan Xu; Kaustubh H Kulkarni; Rashim Singh; Zhen Yang; Stephen W J Wang; Vincent H Tam; Ming Hu
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

Review 7.  Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?

Authors:  Breland Smith; Federico Medda; Vijay Gokhale; Travis Dunckley; Christopher Hulme
Journal:  ACS Chem Neurosci       Date:  2012-08-28       Impact factor: 4.418

Review 8.  Anticancer activity of green tea polyphenols in prostate gland.

Authors:  Pierpaola Davalli; Federica Rizzi; Andrea Caporali; Davide Pellacani; Serena Davoli; Saverio Bettuzzi; Maurizio Brausi; Domenico D'Arca
Journal:  Oxid Med Cell Longev       Date:  2012-05-15       Impact factor: 6.543

9.  Chronic inflammation in cancer development.

Authors:  Gabriele Multhoff; Michael Molls; Jürgen Radons
Journal:  Front Immunol       Date:  2012-01-12       Impact factor: 7.561

10.  Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages.

Authors:  So-Young Joo; Young-A Song; Young-Lan Park; Eun Myung; Cho-Yun Chung; Kang-Jin Park; Sung-Bum Cho; Wan-Sik Lee; Hyun-Soo Kim; Jong-Sun Rew; Nack-Sung Kim; Young-Eun Joo
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.